Abstract: The present invention generally relates to Ligand-drug conjugates of the Formula I: or pharmaceutically acceptable salts, stereoisomers or isotopes thereof. The invention further relates to the use of the compound of Formula I, for the treatment of cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202547074005-STATEMENT OF UNDERTAKING (FORM 3) [04-08-2025(online)].pdf | 2025-08-04 |
| 2 | 202547074005-REQUEST FOR EXAMINATION (FORM-18) [04-08-2025(online)].pdf | 2025-08-04 |
| 3 | 202547074005-PRIORITY DOCUMENTS [04-08-2025(online)].pdf | 2025-08-04 |
| 4 | 202547074005-FORM 18 [04-08-2025(online)].pdf | 2025-08-04 |
| 5 | 202547074005-FORM 1 [04-08-2025(online)].pdf | 2025-08-04 |
| 6 | 202547074005-DECLARATION OF INVENTORSHIP (FORM 5) [04-08-2025(online)].pdf | 2025-08-04 |
| 7 | 202547074005-COMPLETE SPECIFICATION [04-08-2025(online)].pdf | 2025-08-04 |
| 8 | 202547074005-FORM-26 [05-08-2025(online)].pdf | 2025-08-05 |